Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

chronic myelogenous leukemia

Showing 1-1 of about 1 articles.

Lixte Biotechnology Holdings, Inc.

LB-100 and LB-102, Lixte Biotechnology’s Protein Phosphatase 2A Inhibitors, Sensitize BCR-ABL Leukemia Stem Cells to Targeted Therapy with Tyrosine Kinase Inhibitors

February 09, 2018

Showing 1-1 of about 1 articles.

© 2018 GlobeNewswire, Inc. All Rights Reserved.